The 2021 Conference builds on prior very successful conference series and leverages learnings from Regulators and international experts in the field. Clinical trial sponsors and academia are facing a host of new registration requirements in Europe in comparison with other regions. With evolving requirements comes new challenges, creating additional opportunities for knowledge-sharing and necessitating more interaction with peers. This event will provide essentials and timely information about global clinical trial disclosure, data transparency, data sharing for secondary research and updates on the EU Clinical Trial Information System (CTIS) and how Brexit is impacting the disclosure ecosystem. It brings leading study sponsors from Industry and Academia together with regulators and other players to exchange knowledge and share their experiences with the implementation of Clinical Trial Disclosure and Data Transparency from various viewpoints.
Want to learn more about Clinical Trial Disclosure & Data Transparency Conference? You've come to the right site!
Short Course or Primer
To keep you at the forefront.
Merete Joergensen, MBA, MSc Clinical Disclosure and Transparency Expert, Former EFPIA, CREG Clinical Trials
Merete-J Consulting CVR: 34920818, Denmark
Scott Feiner Senior Manager, Clinical Records Management, Strategic Clinical Operations
AbbVie, United States
Robert Paarlberg, MS Principal
Nate Root, MSc Associate Director, Disclosure and Transparency
Ionis Pharmaceuticals, United States
Matthias Zerm, PhD Lead Expert, Clinical Trial Disclosure and R&D Processes
Thomas Schindler, PhD Director Global Regulatory Affairs - Regulatory Operations
BioNTech SE, Germany
Sameer Sharma, MPharm Associate Director, Clinical Trial Transparency
Merck KGaA, Germany
Have an account?